Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Professional Diversity Network | IPDN | Nov 22, 2024 | 0.80 | +6.97 |
Proficient Auto Logistics | PAL | Nov 22, 2024 | 9.80 | +2.73 |
Profire Energy | PFIE | Nov 22, 2024 | 2.52 | 0.00 |
Profound Medical | PROF | Nov 22, 2024 | 7.55 | +0.40 |
ProFrac A | ACDC | Nov 22, 2024 | 7.75 | +2.65 |
PROG | PRG | Nov 22, 2024 | 47.43 | +2.35 |
Progress Software | PRGS | Nov 22, 2024 | 69.25 | +0.76 |
Progressive | PGR | Nov 22, 2024 | 266.06 | +0.99 |
Progyny | PGNY | Nov 22, 2024 | 15.44 | +3.14 |
ProKidney | PROK | Nov 22, 2024 | 1.69 | -2.87 |
Prologis | PLD | Nov 22, 2024 | 115.80 | +1.61 |
ProMIS Neurosciences | PMN | Nov 22, 2024 | 1.03 | +7.80 |
PropertyGuru | PGRU | Nov 22, 2024 | 6.64 | +0.15 |
ProPetro | PUMP | Nov 22, 2024 | 8.50 | +3.41 |
ProPhase Labs | PRPH | Nov 22, 2024 | 0.77 | -1.03 |
ProQR Therapeutics | PRQR | Nov 22, 2024 | 3.62 | +0.28 |
PROS | PRO | Nov 22, 2024 | 23.92 | +1.23 |
ProShares Bitcoin Strategy ETF | BITO | Nov 22, 2024 | 26.69 | +0.98 |
Proshares Ultra FTSE Europe | UPV | Nov 22, 2024 | 56.66 | +0.63 |
ProShares UltraShort Bloomberg Natural Gas | KOLD | Nov 22, 2024 | 61.63 | +11.25 |
Proshares Ultrashort FTSE Europe | EPV | Nov 22, 2024 | 41.04 | -0.10 |
Prospect Capital | PSEC | Nov 22, 2024 | 4.83 | +3.87 |
Prospect Capital A Pref | PSEC-A | Nov 22, 2024 | 19.15 | +0.53 |
Prosperity Bancshares | PB | Nov 22, 2024 | 84.30 | +2.38 |
Protagenic Therapeutics | PTIX | Nov 22, 2024 | 0.65 | +6.91 |
Protagonist Therapeutics | PTGX | Nov 22, 2024 | 46.46 | +11.55 |
Protalix Bio Therapeutics | PLX | Nov 22, 2024 | 1.69 | +1.81 |
Protara Therapeutics | TARA | Nov 22, 2024 | 2.39 | +4.37 |
Prothena | PRTA | Nov 22, 2024 | 14.60 | +1.11 |
Proto Labs | PRLB | Nov 22, 2024 | 41.50 | +4.43 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.